Skip to main content
Erschienen in: Infection 1/2015

01.02.2015 | Original Paper

Radiologic and laboratory differences in patients with tuberculous and parapneumonic pleural effusions showing non-lymphocytic predominance and high adenosine deaminase levels

verfasst von: J. Lee, S. Y. Lee, J. K. Lim, S. S. Yoo, S. Y. Lee, S. I. Cha, J. Y. Park, C. H. Kim

Erschienen in: Infection | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Tuberculous pleural effusion (TPE) is characterized by lymphocytic predominance and high adenosine deaminase (ADA) levels. However, TPEs sometimes present non-lymphocytic predominance, and parapneumonic effusion (PPE) often exceeds the cutoff value of ADA for TPE. Thus, the differential diagnosis of cases with pleural fluid (PF) showing non-lymphocytic predominance and high ADA levels is challenging. However, limited data concerning the clinical differences in these patients are available.

Methods

A retrospective study was conducted on TPE and PPE patients with PF showing non-lymphocytic predominance and ADA levels ≥40 U/L in 2009–2013 in a South Korean tertiary referral hospital. The clinical, laboratory, and computed tomography (CT) findings between the groups were analyzed using multivariate logistic regression to develop a prediction model with independent factors for TPE.

Results

Among 353 patients with TPE, 24 (6.8 %) showed PF with non-lymphocytic predominance and ADA levels of ≥40 U/L. Twenty-eight PPE patients who presented PF findings comparable with those of TPE patients were included in the control group. In the final analysis, PF ADA levels >58 U/L and nodular lung lesions on CT were independent positive predictors, while loculated effusion was an independent negative predictor for TPE. Using the prediction model, a score ≥ +3 provided a sensitivity of 88 %, specificity of 93 %, positive predictive value of 91 %, and negative predictive value of 90 % for TPE.

Conclusion

PF ADA levels, nodular lung lesions, and loculated pleural effusion may help differentiate TPE from PPE in patients with PF showing non-lymphocytic predominance and ADA levels ≥40 U/L.
Literatur
1.
Zurück zum Zitat Krenke R, Korczynski P. Use of pleural fluid levels of adenosine deaminase and interferon gamma in the diagnosis of tuberculous pleuritis. Curr Opin Pulm Med. 2010;16:367–75.PubMedCrossRef Krenke R, Korczynski P. Use of pleural fluid levels of adenosine deaminase and interferon gamma in the diagnosis of tuberculous pleuritis. Curr Opin Pulm Med. 2010;16:367–75.PubMedCrossRef
2.
Zurück zum Zitat Liang QL, Shi HZ, Wang K, et al. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med. 2008;102:744–54.PubMedCrossRef Liang QL, Shi HZ, Wang K, et al. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med. 2008;102:744–54.PubMedCrossRef
4.
Zurück zum Zitat Levine H, Szanto PB, Cugell DW. Tuberculous pleurisy. An acute illness. Arch Intern Med. 1968;122:329–32.PubMedCrossRef Levine H, Szanto PB, Cugell DW. Tuberculous pleurisy. An acute illness. Arch Intern Med. 1968;122:329–32.PubMedCrossRef
5.
Zurück zum Zitat Gopi A, Madhavan SM, Sharma SK, et al. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest. 2007;131:880–9.PubMedCrossRef Gopi A, Madhavan SM, Sharma SK, et al. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest. 2007;131:880–9.PubMedCrossRef
6.
Zurück zum Zitat Lin MT, Wang JY, Yu CJ, et al. Mycobacterium tuberculosis and polymorphonuclear pleural effusion: incidence and clinical pointers. Respir Med. 2009;103:820–6.PubMedCrossRef Lin MT, Wang JY, Yu CJ, et al. Mycobacterium tuberculosis and polymorphonuclear pleural effusion: incidence and clinical pointers. Respir Med. 2009;103:820–6.PubMedCrossRef
7.
Zurück zum Zitat Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med. 2010;21:419–23.PubMedCrossRef Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med. 2010;21:419–23.PubMedCrossRef
8.
Zurück zum Zitat Sahn SA, Huggins JT, San Jose ME, et al. Can tuberculous pleural effusions be diagnosed by pleural fluid analysis alone? Int J Tuberc Lung Dis. 2013;17:787–93.PubMedCrossRef Sahn SA, Huggins JT, San Jose ME, et al. Can tuberculous pleural effusions be diagnosed by pleural fluid analysis alone? Int J Tuberc Lung Dis. 2013;17:787–93.PubMedCrossRef
9.
Zurück zum Zitat Light RW. Pleural disease. 3rd ed. Baltimore: Williams and Wilkins; 1995. Chapter 9. Parapneumonic effusions and empyema. p. 129–53. Light RW. Pleural disease. 3rd ed. Baltimore: Williams and Wilkins; 1995. Chapter 9. Parapneumonic effusions and empyema. p. 129–53.
10.
Zurück zum Zitat World Health Organization. Tuberculosis. Available at: http://www.who.int./tb. WHO report. 2012. World Health Organization. Tuberculosis. Available at: http://​www.​who.​int.​/​tb.​ WHO report. 2012.
11.
Zurück zum Zitat Bielsa S, Palma R, Pardina M, et al. Comparison of polymorphonuclear- and lymphocyte-rich tuberculous pleural effusions. Int J Tuberc Lung Dis. 2013;17:85–9.PubMedCrossRef Bielsa S, Palma R, Pardina M, et al. Comparison of polymorphonuclear- and lymphocyte-rich tuberculous pleural effusions. Int J Tuberc Lung Dis. 2013;17:85–9.PubMedCrossRef
12.
Zurück zum Zitat Lee J, Lee SY, Yoo SS, et al. Clinical value of whole-blood interferon-gamma assay in patients with suspected pulmonary tuberculosis and AFB smear- and polymerase chain reaction-negative bronchial aspirates. Diagn Microbiol Infect Dis. 2012;73:252–6.PubMedCrossRef Lee J, Lee SY, Yoo SS, et al. Clinical value of whole-blood interferon-gamma assay in patients with suspected pulmonary tuberculosis and AFB smear- and polymerase chain reaction-negative bronchial aspirates. Diagn Microbiol Infect Dis. 2012;73:252–6.PubMedCrossRef
13.
Zurück zum Zitat Kim HJ, Lee HJ, Kwon SY, et al. The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis. Chest. 2006;129:1253–8.PubMedCrossRef Kim HJ, Lee HJ, Kwon SY, et al. The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis. Chest. 2006;129:1253–8.PubMedCrossRef
14.
Zurück zum Zitat Maji A, Maikap MK, Jash D, et al. Role of common investigations in aetiological evaluation of exudative pleural effusions. J Clin Diagn Res. 2013;7:2223–6.PubMedCentralPubMed Maji A, Maikap MK, Jash D, et al. Role of common investigations in aetiological evaluation of exudative pleural effusions. J Clin Diagn Res. 2013;7:2223–6.PubMedCentralPubMed
15.
Zurück zum Zitat Valdes L, San Jose E, Alvarez D, et al. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest. 1993;103:458–65.PubMedCrossRef Valdes L, San Jose E, Alvarez D, et al. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest. 1993;103:458–65.PubMedCrossRef
16.
Zurück zum Zitat Ocana I, Martinez-Vazquez JM, Segura RM, et al. Adenosine deaminase in pleural fluids. Test for diagnosis of tuberculous pleural effusion. Chest. 1983;84:51–3.PubMedCrossRef Ocana I, Martinez-Vazquez JM, Segura RM, et al. Adenosine deaminase in pleural fluids. Test for diagnosis of tuberculous pleural effusion. Chest. 1983;84:51–3.PubMedCrossRef
17.
Zurück zum Zitat Lee J, Lee SY, Choi KJ, et al. Clinical utility of CT-based bronchial aspirate TB-PCR for the rapid diagnosis of pleural tuberculosis. Tuberc Respir Dis (Seoul). 2013;75:150–6.CrossRef Lee J, Lee SY, Choi KJ, et al. Clinical utility of CT-based bronchial aspirate TB-PCR for the rapid diagnosis of pleural tuberculosis. Tuberc Respir Dis (Seoul). 2013;75:150–6.CrossRef
18.
Zurück zum Zitat Im JG, Itoh H, Shim YS, et al. Pulmonary tuberculosis: CT findings–early active disease and sequential change with antituberculous therapy. Radiology. 1993;186:653–60.PubMedCrossRef Im JG, Itoh H, Shim YS, et al. Pulmonary tuberculosis: CT findings–early active disease and sequential change with antituberculous therapy. Radiology. 1993;186:653–60.PubMedCrossRef
19.
20.
Zurück zum Zitat Wang YH, Lin AS, Lai YF, et al. The high value of high-resolution computed tomography in predicting the activity of pulmonary tuberculosis. Int J Tuberc Lung Dis. 2003;7:563–8.PubMed Wang YH, Lin AS, Lai YF, et al. The high value of high-resolution computed tomography in predicting the activity of pulmonary tuberculosis. Int J Tuberc Lung Dis. 2003;7:563–8.PubMed
21.
Zurück zum Zitat Lee HM, Shin JW, Kim JY, et al. HRCT and whole-blood interferon-gamma assay for the rapid diagnosis of smear-negative pulmonary tuberculosis. Respiration. 2010;79:454–60.PubMedCrossRef Lee HM, Shin JW, Kim JY, et al. HRCT and whole-blood interferon-gamma assay for the rapid diagnosis of smear-negative pulmonary tuberculosis. Respiration. 2010;79:454–60.PubMedCrossRef
22.
Zurück zum Zitat Kim CH, Lim JK, Lee SY, et al. Predictive factors for tuberculosis in patients with a TB-PCR negative bronchial aspirate. Infection. 2013;41:187–94.PubMedCrossRef Kim CH, Lim JK, Lee SY, et al. Predictive factors for tuberculosis in patients with a TB-PCR negative bronchial aspirate. Infection. 2013;41:187–94.PubMedCrossRef
23.
Zurück zum Zitat Kwon JS, Cha SI, Jeon KN, et al. Factors influencing residual pleural opacity in tuberculous pleural effusion. J Korean Med Sci. 2008;23:616–20.PubMedCentralPubMedCrossRef Kwon JS, Cha SI, Jeon KN, et al. Factors influencing residual pleural opacity in tuberculous pleural effusion. J Korean Med Sci. 2008;23:616–20.PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Han DH, Song JW, Chung HS, et al. Resolution of residual pleural disease according to time course in tuberculous pleurisy during and after the termination of antituberculosis medication. Chest. 2005;128:3240–5.PubMedCrossRef Han DH, Song JW, Chung HS, et al. Resolution of residual pleural disease according to time course in tuberculous pleurisy during and after the termination of antituberculosis medication. Chest. 2005;128:3240–5.PubMedCrossRef
25.
Zurück zum Zitat Cases Viedma E, Lorenzo Dus MJ, Gonzalez-Molina A, et al. A study of loculated tuberculous pleural effusions treated with intrapleural urokinase. Respir Med. 2006;100:2037–42.PubMedCrossRef Cases Viedma E, Lorenzo Dus MJ, Gonzalez-Molina A, et al. A study of loculated tuberculous pleural effusions treated with intrapleural urokinase. Respir Med. 2006;100:2037–42.PubMedCrossRef
27.
Zurück zum Zitat Valdes L, Alvarez D, San Jose E, et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med. 1998;158:2017–21.PubMedCrossRef Valdes L, Alvarez D, San Jose E, et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med. 1998;158:2017–21.PubMedCrossRef
Metadaten
Titel
Radiologic and laboratory differences in patients with tuberculous and parapneumonic pleural effusions showing non-lymphocytic predominance and high adenosine deaminase levels
verfasst von
J. Lee
S. Y. Lee
J. K. Lim
S. S. Yoo
S. Y. Lee
S. I. Cha
J. Y. Park
C. H. Kim
Publikationsdatum
01.02.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 1/2015
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0697-y

Weitere Artikel der Ausgabe 1/2015

Infection 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.